MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202621072040 A) filed by Dr Poona Nath Chouhan; Dr Sapna Thakur; Dr Neeraj Kumar; Dr Divya; Dr Avinash Wade; Dr Sneha Panzade; Dr Prakash Choudhary; Dr Jetha Ram Nokhawal; Dr Ganesh Dan; and Dr Hemant Rajpurohit on June 10, 2026, for Polyherbal Ethosomal Formulation Of Silver Nanoparticles And Ashwagandha For Management Of Burns.
Inventors include Dr Poona Nath Chouhan; Dr Sapna Thakur; Dr Neeraj Kumar; Dr Divya; Dr Avinash Wade; Dr Sneha Panzade; Dr Prakash Choudhary; Dr Jetha Ram Nokhawal; Dr Ganesh Dan; and Dr Hemant Rajpurohit.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: ABSTRACT The present invention relates to a polyherbal ethosomal formulation comprising biosynthesized silver nanoparticles and standardized Withania somnifera (Ashwagandha) extract for management of burn wounds. The active constituents are encapsulated within phospholipid-based ethosomal vesicles to enhance skin penetration, retention, and therapeutic efficacy. The formulation exhibits potent antimicrobial, antioxidant, anti-inflammatory, and wound-healing properties. Experimental studies demonstrated enhanced wound contraction, accelerated epithelialization, increased collagen deposition, reduced oxidative stress, and superior tissue regeneration compared with conventional treatments. The formulation may be administered as a gel, cream, hydrogel dressing, film, patch, or spray and provides an effective, safe, and synergistic therapeutic approach for burn wound management.
Disclaimer: Curated by HT Syndication.
